Overpatented, Overpriced: Special Humira Edition

The following case study on Humira is the first of a series of in-depth investigations into the best-selling medicines in I-MAK's Overpatented, Overpriced report.

Download the Report

Join us to stay updated
and help make lifesaving medicines accessible to all